The Senior Director, Medical Monitor will provide medical oversight for late-stage respiratory clinical trials, ensuring patient safety and protocol compliance. They will also collaborate cross-functionally to interpret clinical data and contribute to regulatory filings and study reports.
The Senior Director will set the strategic direction and lead the execution of analytical development for biologics programs within a virtual development model. They will manage external CDMO partnerships, oversee GMP compliance, and ensure analytical strategies support commercialization readiness.
The Vice President will lead late-stage Immunology and Inflammation programs, shaping integrated development strategies and guiding cross-functional teams through regulatory submission. They are responsible for building a high-performing team of physicians and scientists while ensuring clinical excellence and alignment with corporate objectives.
The Director will serve as the clinical science lead for respiratory programs, driving protocol development, study execution, and regulatory documentation. They will collaborate with cross-functional teams to ensure data quality, participant safety, and alignment with clinical development milestones.
